News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Moss Genomics Announces Private Placement and Agreement to Acquire Ethereum
February 4, 2025
·
4 min read
Press Releases
Hemostemix Expands to the Dominican Republic
February 3, 2025
·
6 min read
Press Releases
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration
February 3, 2025
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
February 3, 2025
·
4 min read
Press Releases
Scryb Secures Over $1.1M in Convertible Debenture Financing, Led by Plaza Capital
February 3, 2025
·
6 min read
Press Releases
Izotropic to Present at Investor Conference February 6th
February 3, 2025
·
4 min read
Press Releases
Moss Genomics Announces Closing of Private Placement, Acquisition of 160 Ethereum Cryptocurrency (ETH) and Welcomes Hunter Jordan to Its Board of Directors
February 3, 2025
·
5 min read
Press Releases
Defence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million
January 31, 2025
·
4 min read
Press Releases
Medexus Schedules Third Fiscal Quarter 2025 Conference Call
January 31, 2025
·
3 min read
Press Releases
Medexus Pharmaceuticals Announces Closing of $30 Million Overnight Marketed Public Offering of Common Shares
January 31, 2025
·
4 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us